每周股票复盘：塞力医疗（603716）股东户数下降1.94%

Core Viewpoint - The stock of Saily Medical (603716) has experienced significant fluctuations, with a recent increase in price and notable trading activity, despite a substantial decline in revenue and profit as reported in the latest financial disclosures [1][3][5]. Trading Information - As of August 29, 2025, Saily Medical's stock closed at 33.95 yuan, up 7.71% from the previous week, with a peak price of 38.12 yuan on August 26, marking a near one-year high [1]. - The stock was listed on the "Dragon and Tiger List" due to a cumulative price deviation exceeding 20% over three consecutive trading days [3][7]. Shareholder Changes - As of June 30, 2025, the number of shareholders decreased to 45,700, a reduction of 902, or 1.94%, compared to March 31, 2025 [4][7]. Financial Performance - The mid-year report for 2025 indicates a significant decline in revenue, with total revenue at 584 million yuan, down 40.2% year-on-year, and a net loss attributable to shareholders of 56.12 million yuan, a decrease of 1075.89% [5][8]. - The second quarter alone reported a revenue of 296 million yuan, down 39.65% year-on-year, with a net loss of 41.80 million yuan, reflecting a 427.14% decline [5]. Company Announcements - The company announced that its stock experienced abnormal trading fluctuations, confirming that there were no undisclosed significant information affecting the stock price [6][7]. - The board of directors approved several resolutions, including the mid-year report and changes to corporate governance, with a shareholder meeting scheduled for September 15, 2025 [9][11].